Food and Drug Administration
Briefing Information
Bristol-Myers Squibb Company
Disclaimer
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Pargluva™ (Muraglitzzar) Briefing Information
FDA
Disclaimer
Portions of this document have been determined to be
exempt from disclosure under the Freedom of Information Act (the FOIA) (5
U.S.C. ยง552).
These redacted portions will appear as white space on the screen or on the
printed page.